Charcoal suspension for tumor labelling modifies macrophage activity in mice

Life Sciences

Volumn 66, Issue 9, 2000, Pages 817-827

  Bonhomme Faivre, L ^a   Depraetere, P ^b   Savelli, M P ^c   Amdidouche, D ^a   Bizi, E ^a   Seiller, M ^b   Orbach Arbouys, S ^a  

^a HÔPITAL PAUL BROUSSE   (France)

^b Ecl Natl Sup Chim Clermont F   (France)

^c UNIVERSITÉ DE PICARDIE JULES VERNE   (France)

Author keywords

Charcoal suspension; Chemoluminescence; Excipient; Macrophage activation; Macrophage mobilization

Indexed keywords

CHARCOAL; EXCIPIENT;

ANIMAL CELL; ARTICLE; BREAST CANCER; CHEMOLUMINESCENCE; INJECTION SITE; LABELING INDEX; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; SUSPENSION; TUMOR GROWTH; TUMOR LOCALIZATION; ZETA POTENTIAL;

ANIMALS; AREA UNDER CURVE; CHARCOAL; CHEMILUMINESCENT MEASUREMENTS; CYTOPLASMIC GRANULES; FEMALE; HUMANS; MACROPHAGES, PERITONEAL; MICE; NEOPLASMS, EXPERIMENTAL; PARTICLE SIZE; PHAGOCYTOSIS; SURFACE-ACTIVE AGENTS; SUSPENSIONS;

ANIMALIA;

EID: 0034695606     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(99)00654-2     Document Type: Article

References (16)

1. L. Bonhomme, M.C. Mathieu, M. Seiller, M. Bretou, G. Fredj, and J. Alarcon, Eur. J. Pharm. Sci. 1 103-108 (1993).
2. L. Bonhomme-Faivre, M.C. Mathieu, J.L. Grossiord, P. Depraetere, G. Couaraze, S. Orbach-Arbouys, F. Puisieux, M. Seiller, Pharmaceutical Research. 14 218-223 (1997).
3. L. Bonhomme-Faivre, M.C. Mathieu, P. Depraetere, J.L. Grossiord, G. Couaraze, F. Puisieux, S. Orbach-Arbouys, M. Seiller, Drug Development and Industrial Pharmacy. 25 175-186 (1999).
4. US Pharmacopeia, 22nd Revision. Easton Mack Publishing Compagny: 1483-1487 (1991).
5. US Pharmacopeia, 22nd Revision Easton, Mack Publishing Company: 1493-1495 (1991)
6. P. Depraetere. Spectra 2000 16 132, 30-36 (1988).
7. A. Bravo-Cuellar, D. Scott Algara, G. Metzger, and S. Orbach-Arbouys, Cancer Res. 47 3477-84 (1987).
8. L. Pillemer, M.D. Schoenberg, Z. Blum, and L. Wurz, Science. 122 3169, 545-549 (1955).
9. J. Schnyder, and M. Baggiolini, J.Exp.Med. 148 1449-1457 (1978).
10. L. Illum, S.S. Davis, R.H. Müller, E. Mak, and P. West, Life Sciences, 40 367-374 (1987).
11. C. Stiffel, ThèSe SéRie A N° 3019. (1956). Faculté des sciences. Université de Paris.
12. L. Bonhomme-Faivre, M. Seiller, Bizi E., P. Depraetere, J.L. Grossiord, G. Fredj, S. Orbach-Arbouys, STP. Pharma Sciences. 56447-451 (1995).
13. L. Bonhomme-Faivre, M.C. Mathieu, P. Depraetere, J.L. Grossiord, M. Seiller. Int. J. Pharm. 152 251-255 (1997).
14. A.C. Allison, J.S. Marington, M.J. Bisbeck. Exp.Med. 124 141-53 (1966)
15. D.G. Hopper, M.V. Pimm, and R.W. Baldwin, Cancer. Immunol. Immunothe. 1 143-144 (1976).
16. D.S. Chervinsky, M.L. Brecker, and M.J. Hoelle, 83rd Annual Meeting of the American Association for Cancer Research, May 20-23, 1992, San Diego, California, p. 33, abstract no. 2851.